Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics

In Vitro Diagnostics

GNA Biosolutions reveals new ultrafast PCR platform at Medica German molecular technology firm GNA Biosolutions has launched Pharos V8, the world's first Laser PCR platform.
Diagnostics > In Vitro Diagnostics > News
Inotrem, Roche Diagnostics partner to develop companion diagnostic test Inotrem has signed a R&D collaboration agreement with Roche Diagnostics to develop a companion diagnostic test using a soluble plasma circulating protein (sTREM-1) developed by Inotrem and the Roche proprietary Elecsys platform.
Diagnostics > In Vitro Diagnostics > News Roche gets FDA approval for Ventana ALK CDx assay to identify lung cancer patients eligible for treatment with Alecensa Roche has obtained US Food and Drug Administration (FDA) approval for the Ventana ALK (D5F3) CDx assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC) patients eligible for treatment with the Roche medicine ALECENSA (alectinib).
Diagnostics > In Vitro Diagnostics > News
See more In Vitro Diagnostics news

Latest In Vitro Diagnostics News and Insight

View all In Vitro Diagnostics news or find news targeted to your interests
Roche gets FDA approval for Ventana ALK CDx assay to identify lung cancer patients eligible for treatment with Alecensa
Roche has obtained US Food and Drug Administration (FDA) approval for the Ventana ALK (D5F3) CDx assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC) patients eligible for treatment with the Roche medicine ALECENSA (alectinib).
Diagnostics > In Vitro Diagnostics > News
Sysmex America gets FDA nod for complete blood cell count test
By MDBR Staff Writer
Sysmex America has secured approval from the US Food and Drug Administration (FDA) for a complete blood cell count (CBC) test.
Diagnostics > In Vitro Diagnostics > News
Natera selected for UK longitudinal breast cancer liquid biopsy study
By MDBR Staff Writer
Imperial College London and the University of Leicester have selected genetic testing company Natera for longitudinal circulating tumor DNA study in breast cancer.
Diagnostics > In Vitro Diagnostics > News
LRE Medical is proud to announce that it will be exhibiting at the Association for Molecular Pathology (AMP) 2017
The Annual Meeting runs from November 16-18, 2017 in the Calvin L. Rampton Convention Center, Salt Lake City, Utah.
Diagnostics > In Vitro Diagnostics > Press Releases
LRE Medical is proud to announce that it will be exhibiting at MEDICA 2017, a globally renowned forum for medicine.
The upcoming edition will be held from the 13th to the 16th of November in Messe Dusseldorf. It will welcome nearly 6,000 exhibitors and over 120,000 professional visitors from around the world. Medica 2017 will present the latest in medical and information technology, laboratory equipment, diagnostics and physiotherapy.
Diagnostics > In Vitro Diagnostics > Press Releases
Luminex receives FDA clearance for ARIES Group A Strep assay
Luminex announced that it has received FDA clearance for the ARIES Group A Strep assay, a moderate complexity, sample to answer test for the direct detection of Streptococcus pyogenes from throat swab specimens using the ARIES® System.
Diagnostics > In Vitro Diagnostics > News
View all In Vitro Diagnostics news or find news targeted to your interests